Anti-METTL4 抗体

ターゲットの情報

N(6)-adenine-specific methyltransferase that can methylate both RNAs and DNA (PubMed : 31913360, PubMed : 32183942). Acts as a N(6)-adenine-specific RNA methyltransferase by catalyzing formation of N6,2'-O-dimethyladenosine (m6A(m)) on internal positions of U2 small nuclear RNA (snRNA) : methylates the 6th position of adenine residues with a pre-deposited 2'-O-methylation (PubMed : 31913360). Internal m6A(m) methylation of snRNAs regulates RNA splicing (PubMed : 31913360). Also able to act as a N(6)-adenine-specific DNA methyltransferase by mediating methylation of DNA on the 6th position of adenine (N(6)-methyladenosine) (PubMed : 32183942). The existence of N(6)-methyladenosine (m6A) on DNA is however unclear in mammals, and additional evidences are required to confirm the role of the N(6)-adenine-specific DNA methyltransferase activity of METTL4 in vivo (PubMed : 32203414). Acts as a regulator of mitochondrial transcript levels and mitochondrial DNA (mtDNA) copy number by mediating mtDNA N(6)-methylation : m6A on mtDNA reduces transcription by repressing TFAM DNA-binding and bending (PubMed : 32183942). N(6)-methyladenosine deposition by METTL4 regulates Polycomb silencing by triggering ubiquitination and degradation of sensor proteins ASXL1 and MPND, leading to inactivation of the PR-DUB complex and subsequent preservation of Polycomb silencing (By similarity).